208 related articles for article (PubMed ID: 37686622)
1. Efficacy of Thermal Ablation for Small-Size (0-3 cm) versus Intermediate-Size (3-5 cm) Colorectal Liver Metastases: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE).
Dijkstra M; van der Lei S; Puijk RS; Schulz HH; Vos DJW; Timmer FEF; Scheffer HJ; Buffart TE; van den Tol MP; Lissenberg-Witte BI; Swijnenburg RJ; Versteeg KS; Meijerink MR
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686622
[TBL] [Abstract][Full Text] [Related]
2. Unresectable Intermediate-Size (3-5 cm) Colorectal Liver Metastases: Stereotactic Ablative Body Radiotherapy Versus Microwave Ablation (COLLISION-XL): Protocol of a Phase II/III Multicentre Randomized Controlled Trial.
van der Lei S; Dijkstra M; Nieuwenhuizen S; Schulz HH; Vos DJW; Versteeg KS; Buffart TE; Swijnenburg RJ; de Vries JJJ; Bruynzeel AME; van den Tol MP; Scheffer HJ; Puijk RS; Haasbeek CJA; Meijerink MR;
Cardiovasc Intervent Radiol; 2023 Aug; 46(8):1076-1085. PubMed ID: 37430016
[TBL] [Abstract][Full Text] [Related]
3. Thermal Ablation Compared to Partial Hepatectomy for Recurrent Colorectal Liver Metastases: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study.
Dijkstra M; Nieuwenhuizen S; Puijk RS; Timmer FEF; Geboers B; Schouten EAC; Opperman J; Scheffer HJ; Vries JJJ; Swijnenburg RJ; Versteeg KS; Lissenberg-Witte BI; van den Tol MP; Meijerink MR
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199556
[TBL] [Abstract][Full Text] [Related]
4. Primary Tumor Sidedness, RAS and BRAF Mutations and MSI Status as Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Surgery and Thermal Ablation: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE).
Dijkstra M; Nieuwenhuizen S; Puijk RS; Timmer FEF; Geboers B; Schouten EAC; Opperman J; Scheffer HJ; de Vries JJJ; Versteeg KS; Lissenberg-Witte BI; van den Tol MP; Meijerink MR
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440165
[TBL] [Abstract][Full Text] [Related]
5. Thermal Ablation versus Stereotactic Ablative Body Radiotherapy to Treat Unresectable Colorectal Liver Metastases: A Comparative Analysis from the Prospective Amsterdam CORE Registry.
Nieuwenhuizen S; Dijkstra M; Puijk RS; Timmer FEF; Nota IM; Opperman J; van den Bemd B; Geboers B; Ruarus AH; Schouten EAC; de Vries JJJ; Scheffer HJ; van Geel AM; van Waesberghe JHTM; Swijnenburg RJ; Versteeg KS; Lissenberg-Witte BI; van den Tol MP; Haasbeek CJA; Meijerink MR
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503113
[TBL] [Abstract][Full Text] [Related]
6. Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation, and Stereotactic Ablative Body Radiotherapy for Intermediate Size (3-5 cm) Unresectable Colorectal Liver Metastases: a Systematic Review and Meta-analysis.
Nieuwenhuizen S; Dijkstra M; Puijk RS; Geboers B; Ruarus AH; Schouten EA; Nielsen K; de Vries JJJ; Bruynzeel AME; Scheffer HJ; van den Tol MP; Haasbeek CJA; Meijerink MR
Curr Oncol Rep; 2022 Jun; 24(6):793-808. PubMed ID: 35298796
[TBL] [Abstract][Full Text] [Related]
7. Repeat Local Treatment of Recurrent Colorectal Liver Metastases, the Role of Neoadjuvant Chemotherapy: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study.
Dijkstra M; Nieuwenhuizen S; Puijk RS; Timmer FEF; Geboers B; Schouten EAC; Opperman J; Scheffer HJ; de Vries JJJ; Versteeg KS; Lissenberg-Witte BI; Meijerink MR; van den Tol MP
Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638481
[TBL] [Abstract][Full Text] [Related]
8. Improved Outcomes of Thermal Ablation for Colorectal Liver Metastases: A 10-Year Analysis from the Prospective Amsterdam CORE Registry (AmCORE).
Puijk RS; Dijkstra M; van den Bemd BAT; Ruarus AH; Nieuwenhuizen S; Geboers B; Timmer FEF; Schouten EAC; de Vries JJJ; van der Meijs BB; Nielsen K; Swijnenburg RJ; van den Tol MP; Versteeg KS; Lissenberg-Witte BI; Scheffer HJ; Meijerink MR
Cardiovasc Intervent Radiol; 2022 Aug; 45(8):1074-1089. PubMed ID: 35585138
[TBL] [Abstract][Full Text] [Related]
9. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial.
Puijk RS; Ruarus AH; Vroomen LGPH; van Tilborg AAJM; Scheffer HJ; Nielsen K; de Jong MC; de Vries JJJ; Zonderhuis BM; Eker HH; Kazemier G; Verheul H; van der Meijs BB; van Dam L; Sorgedrager N; Coupé VMH; van den Tol PMP; Meijerink MR;
BMC Cancer; 2018 Aug; 18(1):821. PubMed ID: 30111304
[TBL] [Abstract][Full Text] [Related]
10. Role of thermal ablation in the management of colorectal liver metastasis.
Takahashi H; Berber E
Hepatobiliary Surg Nutr; 2020 Feb; 9(1):49-58. PubMed ID: 32140478
[TBL] [Abstract][Full Text] [Related]
11. Oncological outcomes and predictors of radiofrequency ablation of colorectal cancer liver metastases.
Wang CZ; Yan GX; Xin H; Liu ZY
World J Gastrointest Oncol; 2020 Sep; 12(9):1044-1055. PubMed ID: 33005297
[TBL] [Abstract][Full Text] [Related]
12. Local Treatment of Colorectal Liver Metastases in the Presence of Extrahepatic Disease: Survival Outcomes from the Amsterdam Colorectal Liver Met Registry (AmCORE).
Schulz HH; Dijkstra M; van der Lei S; Vos DJW; Timmer FEF; Puijk RS; Scheffer HJ; van den Tol MP; Lissenberg-Witte BI; Buffart TE; Versteeg KS; Swijnenburg RJ; Meijerink MR
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539433
[TBL] [Abstract][Full Text] [Related]
13. The Added Diagnostic Value of Transcatheter CT Hepatic Arteriography for Intraprocedural Detection of Previously Unknown Colorectal Liver Metastases During Percutaneous Ablation and Impact on the Definitive Treatment Plan.
van der Lei S; Opperman J; Dijkstra M; Kors N; Boon R; van den Bemd BAT; Timmer FEF; Nota IMGC; van den Bergh JE; de Vries JJJ; Scheffer HJ; Geboers B; Neuss T; Schouten E; Lissenberg-Witte BI; Puijk RS; Meijerink MR
Cardiovasc Intervent Radiol; 2023 Sep; 46(9):1257-1266. PubMed ID: 37491521
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency versus microwave ablation for intraoperative treatment of colorectal liver metastases.
Krul MF; Gerritsen SL; Vissers FL; Klompenhouwer EG; Ruers TJ; Kuhlmann KF; Kok NF
Eur J Surg Oncol; 2022 Apr; 48(4):834-840. PubMed ID: 34686404
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant Chemotherapy Followed by Radiofrequency Ablation Prolongs Survival for Ablatable Colorectal Liver Metastasis: A Propensity Score Matching Comparative Study.
Chen Y; Xu Y; Xu L; Han F; Huang Y; Jiang H; Wu J; Zhang Y
Front Oncol; 2021; 11():758552. PubMed ID: 34745996
[TBL] [Abstract][Full Text] [Related]
16. Thermal ablation versus hepatic resection for colorectal cancer with synchronous liver metastases: a propensity score matching study.
Xu Y; Zhang Y; Zheng CZ; Li C; Guo T; Xu Y
Eur Radiol; 2022 Oct; 32(10):6678-6690. PubMed ID: 35999370
[TBL] [Abstract][Full Text] [Related]
17. MWA Versus RFA for Perivascular and Peribiliary CRLM: A Retrospective Patient- and Lesion-Based Analysis of Two Historical Cohorts.
van Tilborg AA; Scheffer HJ; de Jong MC; Vroomen LG; Nielsen K; van Kuijk C; van den Tol PM; Meijerink MR
Cardiovasc Intervent Radiol; 2016 Oct; 39(10):1438-46. PubMed ID: 27387188
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases.
Kim KH; Yoon YS; Yu CS; Kim TW; Kim HJ; Kim PN; Ha HK; Kim JC
J Korean Surg Soc; 2011 Jul; 81(1):25-34. PubMed ID: 22066097
[TBL] [Abstract][Full Text] [Related]
19. Surgical approach to microwave and radiofrequency liver ablation for hepatocellular carcinoma and colorectal liver metastases less than 5 cm: a systematic review and meta-analysis.
Abdalla M; Collings AT; Dirks R; Onkendi E; Nelson D; Ozair A; Miraflor E; Rahman F; Whiteside J; Shah MM; Ayloo S; Abou-Setta A; Sucandy I; Kchaou A; Douglas S; Polanco P; Vreeland T; Buell J; Ansari MT; Pryor AD; Slater BJ; Awad Z; Richardson W; Alseidi A; Jeyarajah DR; Ceppa E
Surg Endosc; 2023 May; 37(5):3340-3353. PubMed ID: 36542137
[TBL] [Abstract][Full Text] [Related]
20. Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence.
Mima K; Beppu T; Chikamoto A; Miyamoto Y; Nakagawa S; Kuroki H; Okabe H; Hayashi H; Sakamoto Y; Watanabe M; Kikuchi K; Baba H
Int J Clin Oncol; 2013 Oct; 18(5):847-55. PubMed ID: 22940848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
